Vivo Capital VIII, LLC, 10% Owner at Crinetics Pharmaceuticals, Inc. (CRNX), sold 528 shares at $19.50 ($10K) on 2020-03-09, disclosed to the SEC on 2020-03-11.
Open-market sale of $10k CRNX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $19.50 | 48 | $936 | 9.1% |
| 2 | $19.50 | 133 | $3K | 25.2% |
| 3 | $19.50 | 347 | $7K | 65.7% |
| Total | $19.50 avg | 528 | $10K | 100% |
| Filing → |
| BPMX | SELL | 2019-06-27 | $669K | — | Filing → |
| BPMX | SELL | 2018-03-09 | $720K | — | Filing → |
| BPMX | SELL | 2017-11-13 | $119K | — | Filing → |